Department of TB & Respiratory Diseases
The Department of TB and Respiratory Diseases is actively involved in teaching, training and research in the field of TB & Respiratory Diseases. The faculty of the department assists the government of India in developing strategies for TB control and in implementation of the same. The faculty has contributed significantly to the development of national guidelines in India for management of tuberculosis, MDR- TB and pediatric tuberculosis under the national programme. Dr D. Behera, Dr Rupak Singla and Dr Rohit Sarin are members of various technical committees in the Central Tuberculosis Division at the national level.
The administrative constitution of the department is as follows:-
Head, Dept. of TB & Respiratory Diseases: Dr Rupak Singla
Unit I: (OPO Days: Monday & Thursday)
1. Incharge: Dr Anand Jaiswal
2. Specialist: Dr Anand Jaiswal, Dr S.B. Singh
3. Chief Medical Officers: Dr Vikram Vohra, Dr Sanjay Singh
4. Resident Doctors:
a. Two Senior Residents
b. Four to five Junior Residents
Unit II: (OPO Days: Tuesday & Friday)
1. Incharge: Dr Rupak Singla
2. Specialist: Dr Rupak Singla, Dr Sushil Munjal
3. Chief Medical Officers: Dr Rakesh Aggarwal, Dr Sanjay Gupta
4. Medical Officer: Dr Alok Yadav
5. Resident Doctors:
a. Two Senior Residents
b. Four to five Junior Residents
Unit III: (OPD Days: Wednesday & Saturday)
1. Incharge: Dr M.M. Puri
2. Specialist: Dr M.M. Puri, Dr Lokender
3. Chief Medical Officers: Dr M.P. Arora, Dr Anil Jain
4. Resident Doctors:
a. Two Senior Residents
b. Four to five Junior Residents
Unit IV: (OPD Days: Wednesday & Saturday); Tuesday (Cancer Clinic)
1. Incharge: Dr D. Behera (also Director)
2. Specialist: Dr Rajnish Gupta, Dr J.K. Saini
3. Resident Doctors:
a. One Senior Resident
b. Two Junior Residents
Unit V: (OPD Days: Monday & Thursday)
1. Incharge: Dr Rohit Sarin
2. Chief Medical Officers: Dr Kapil Kumar Mathuria
3. Resident Doctors: To be shared with Unit I
Special Chest Clinics: For patients suffering from various non-tuberculous chest diseases special clinics are also run by the department such as Cancer clinic, smoking cessation clinic, Allergy clinic, Sleep clinic, Physiotherapy Clinic, Air Pollution related diseases clinic.
Inpatient services: The Department has indoor wards for around 450 beds. Currently some of them are under renovation. The department provides inpatient care to tuberculosis, lung cancer and other non-TB respiratory diseases patients and free anti-retrovirus treatment to patients suffering from TB-HIV coinfection. For acutely ill patients the department is equipped with 14 bedded ICU. There are nine experienced senior chest consultants and seven Chief Medical Officers and one medical officer. In addition, there are thirteen senior & 25 junior resident doctors working on tenure basis for the care of the patients.
Emergency Services: Recently (wef 1st April 2009) institute has started emergency ward of 10 beds for care of patients reporting in emergency.
Out Patient Services: The Department has an out-patient department (OPD) with an average daily attendance of 300 - 400 patients. In one year around 32000-33000 new chest symptomatic patients attend the OPD with a total attendance of around one lakh patients per year. A total of around 5000- 6000 TB cases are diagnosed every year. The OPD runs from 9 AM to 1 PM. The registration in OPD is done from 8.45 AM to 12 noon.
Trainings: The Department is actively involved in the training of various medical and paramedical personnel in implementation of strategies under Revised National Tuberculosis Control Programme (RNTCP). The institute also conducts training for Bronchoscopy, Pulmonary Function Tests, Sleep Medicine and ICU. The department is actively involved in organising Continuing Medical Education programme (CME), seminars, conferences on different aspects of diagnosis and management of tuberculosis and respiratory diseases.
Post graduate DNB (Respiratory Medicine) Course: The Institute is recognized centre for post-graduate DNB (Respiratory Diseases) degree course since 1999. Now, w.e.f. 2009, the institute has been accredited for ten DNB seats per year. Regular teaching activities such as seminars, journal club, faculty lectures, grand case presentation, mortality meetings, pathological conference, radiological conference, bed-side clinical round are routinely carried out.
Research Activities: The faculty members of the department are involved in several multi-centric trials at international level and other research projects within the country. Besides this all DNB students submit research projects as a part of their DNB course. The details of the various research activities have been mentioned under research section.
Publications from the Department in 2008-09: The following papers were published in 2008-09:-
1) Sharma S,Sarin R, Khalid UK,Singla N, Sharma PP, Behera D. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India. Int J Tuberc Lung Dis.2008;12:74-80.
2) Behera D. Editorial. Respiratory Medicine in India in the 21st Century. Indian J Chest Dis Allied Sci 2008;50:179-181.
3) D. Behera, R. Aggarwal, A.N. Agarwal, D. Gupta, S.K. Jindal, S.C. Sharma, R. Kapoor, A. Jaiswal. Cost effective chemotherapy (irinoteca and cisplatin) for treatment of lung cancer in developing countries: Observations from India. J Clin Oncol 26:2008 (May 20 suppl; abstr 19121).
4) D.Behera, R.K. Dalai. Lung Cancer in non-smoking Indian wormen : are domestic cooking fuels risk factors? J Thorac Oncol 2008; 4(Suppl 1):S45.
5) D.Behera, R. Aggarwal, A.N. Aggarwal, D. Gupta, S.K. Jindal,S.c. Sharma, R. Kapoor, A. Jaiswal. Gefitinib (Gefitinat) – A molecular targeted therapy in advanced non small lung cancer in Indian patients, A follow-up study. J Thorac Oncol 2008; 4(Suppl 1):S76-S77.
6) D.Behera. Respiratory Medicine in India in the 21st century. Indian J Chest Dis Allied Sci 2008;50:179-181.
7) Sharma M, Khayyam KU, Kumar V, Imam F, Pillai KK, Behera D. Influence of honey on adverse reactions due to anti-tuberculosis drugs in pulmonary tuberculosis patients. Continental J.Pharmacology and Toxicology Research 2008;2:6-11.
8) Shen G, Behera D, Bhalla M, Nadas A, Laal S. Peptide-Based Antibody Detection for Tuberculosis Diagnosis. CLINICAL AND VACCINE IMMUNOLOGY, Jan. 2009, p. 49–54
9) Behera D. Book Review. WHO Report 2008: Global tuberculosis control 2008: Surveillance, Planning, Financing (World Health Organisation, Geneva) 2008. Indian J Med Res 128, 2008,pp89-90.
10) Singla R, Srinath D, Gupta S, Visalakshi P, Khayyam KU, Singla N, Gupta UA, Bharty SK, Behera D. Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India. Int J Tuberc Lung Dis 2009, 13:521-526.
11) Gupta S, Salam N, Srivastava V, Singla R, Behera D, Khayyam KU, Korde R, Malhotra P, Saxena R, Natarajan K. Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis. PLoS ONE 2009, 4(4): e5305. doi:10.1371/journal.pone.0005305
12) Sankar MM, Gopinath K, Singla R and Singh S. In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay. Annals of Clinical Microbiology and Antimicrobials 2008, 7: 1-9.
13) Singla R, Sarin R, Khalid UK, Mathuria K, Singla N, , Jaiswal A, Puri MM, Visalakshi P, Behera D. Seven Years DOTS Plus Pilot Experience in India: Results, Constraints and issues. Accepted for publication in Int J Tuberc Lung Dis.
14) Gupta S, Salam N, Srivastava V, Singla R, Behera D, et al. (2009) Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis. PLoS ONE 4(4): e5305. doi:10.1371/ journal.pone.0005